排序方式: 共有109条查询结果,搜索用时 15 毫秒
1.
2.
3.
嗜麦芽窄食单胞菌耐药特性 总被引:5,自引:0,他引:5
为了解嗜麦芽窄食单胞菌 (Stenotrophomonasmaltophilia)的耐药特性 ,以指导临床用药 ,用微量肉汤稀释法进行药敏试验 ,用双纸片协同试验检测超广谱 β 内酰胺酶 (ESBLs)。结果显示 ,S .maltophilia对包括亚胺培南在内的三代、四代头孢和氨基糖苷类抗生素高度耐药 ,对左旋氧氟沙星、头孢哌酮 /舒巴坦、替卡西林 /克拉维酸、环丙沙星和复方新诺明耐药较低。有 5 2 % (2 6 /5 0 )的菌株产ESBLs,产酶菌对头孢哌酮 /舒巴坦耐药明显高于非产酶菌。可见 ,治疗S .maltophilia感染可首选左旋氧氟沙星、头孢哌酮 /舒巴坦、替卡西林 /克拉维酸或联合用药。产ESBLs的S .maltophilia可能作为传播ESBLs的一个潜在的传染源。 相似文献
4.
目的了解嗜麦芽窄食单胞菌感染的临床特点、危险因素、预后及耐药现状,为有效预防和治疗该病原菌感染提供依据。方法收集2013年11月至2014年4月浙江大学医学院附属第一医院收治的129例细菌培养为嗜麦芽窄食单胞菌患者的临床资料进行回顾性统计分析。结果 129例细菌培养确诊嗜麦芽窄食单胞菌感染患者平均年龄(65.1±17.0)岁,包括下呼吸道感染和非呼吸道感染患者分别为100例和29例,下呼吸道感染患者存在原发肺部疾病的患病率、ICU入住率、气管切开比例、广谱抗生素的使用率、患病年龄等均高于非呼吸道感染患者(P〈0.05)。而非呼吸道感染患者的外科手术、无菌腔内置管比例及免疫抑制剂使用率高于下呼吸道感染患者(P〈0.05)。嗜麦芽窄食单胞菌感染后选择敏感抗生素治疗的患者的死亡率明显低于未选择敏感抗生素的患者(15.0%/30.4%,P〈0.05)。结论原发肺部疾病、入住ICU、气管切开、广谱抗生素使用、年龄大是下呼吸道感染嗜麦芽窄食单胞菌的高危因素,外科手术、无菌腔内置管、免疫抑制剂使用是非呼吸道感染嗜麦芽窄食单胞菌的高危因素。使用敏感抗生素可以降低嗜麦芽窄食单胞菌感染患者的死亡率。 相似文献
5.
Aims: In this study, three facile repetitive‐sequence PCR (rep‐PCR) techniques have been compared with the pulsed‐field gel electrophoresis (PFGE) method for differentiating the genetic relatedness of clinical Stenotrophomonas maltophilia isolates. Methods and Results: The dendrograms of 20 S. maltophilia isolates were constructed based on the data obtained from PFGE and three PCR‐based methods, i.e. enterobacterial repetitive intergenic consensus‐PCR (ERIC‐PCR), BOX‐PCR and repetitive extragenic palindromic‐PCR (REP‐PCR). When compared with PFGE, ERIC‐PCR displayed a much lower discriminatory power, whereas BOX‐PCR and REP‐PCR had a comparable discriminatory power for close genetic‐related isolates. Conclusion: BOX‐PCR and REP‐PCR can be convenient and effective methods for evaluating the close genetic relatedness of clinical S. maltophilia isolates. Significance and Impact of the Study: A rapid method for determining S. maltophilia’s close genetic relatedness provides a convenient tool for understanding the epidemiology of S. maltophilia. 相似文献
6.
Chlorpyrifos is a commonly used organophosphate pesticide. Its extensive use and associated serious soil and water contamination have gained increasing environmental concern. Biodegradation is a promising way to remediate chlorpyrifos contamination. There are many reports on various chlorpyrifos degrading microorganisms, but only a few on biodegradation of chlorpyrifos by consortia. Hence, the present study attempted to assemble a novel bacterial consortium C5 for the biodegradation of chlorpyrifos. The 16S rRNA gene-based molecular analysis revealed that the bacterial consortium consisted of Staphylococcus warneri CPI 2, Pseudomonas putida CPI 9 and Stenotrophomonas maltophilia CPI 15. Optimization of chlorpyrifos degradation by the consortium C5, using a Box–Behnken design, was carried out taking into account four important variables: temperature, pH, the initial concentration of chlorpyrifos and time of incubation. C5 is capable of giving 90% degradation of chlorpyrifos (125 ppm) in 8 days of incubation under optimized conditions of pH (7) and temperature (30°C). Growth curve and degradation study under optimized conditions confirmed that consortium could improve the biodegradation potential. From these results, we conclude that the novel consortium C5 of three species can be used to eliminate chlorpyrifos from various environmental compartments and can be implemented in bioreactors in a cost-effective, safe and environmentally friendly manner. 相似文献
7.
8.
Astaxanthin preparation by fermentation of esters from Haematococcus pluvialis algal extracts with Stenotrophomonas species 下载免费PDF全文
Natural astaxanthin (Ax) is an additive that is widely used because of its beneficial biochemical functions. However, the methods used to produce free Ax have drawbacks. Chemical saponification methods produce several by‐products, and lipase‐catalyzed hydrolysis methods are not cost effective. In this study, a bacterial strain of Stenotrophomonas sp. was selected to enzymatically catalyze the saponification of Ax esters to produce free all‐trans‐Ax. Through single‐factor experiments and a Box–Behnken design, the optimal fermentation conditions were determined as follows: a seed culture age of 37.79 h, an inoculum concentration of 5.92%, and an initial broth pH of 6.80. Under these conditions, a fermentation curve was drawn, and the optimal fermentation time was shown to be 60 h. At 60 h, the degradation rate of the Ax esters was 98.08%, and the yield of free all‐trans‐Ax was 50.130 μg/mL. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:649–656, 2016 相似文献
9.
为了观察和探讨嗜麦芽寡养单胞菌SMP蛋白胞外可调控分泌现象及其机制,将收集到的环境株菌D2株及9株临床株在含不同成分的培养基中培养,取培养液上清利用SDS-PAGE电泳观察SMP蛋白分泌情况;提取各菌株基因组DNA,PCR扩增其smp基因并进行克隆和序列测定;将获得的SMP氨基酸序列用Blastp、Megalign等进行分析,并构建系统发育树。结果显示,不同来源的嗜麦芽寡养单胞菌胞SMP蛋白分泌均存在可调控现象,酵母提取物可抑制该蛋白的分泌,而适宜浓度的麦芽糖则具有促进作用。序列对比及系统发育树分析显示,SMP的氨基酸序列具有种属的特异性,且临床株和环境株中存在一定的差异,临床株中该蛋白的氨基酸序列高度保守,而环境株则序列差异相对明显的,但不同来源的菌株SMP均含有保守的信号肽;提示该蛋白可能与其致病性相关,其胞外分泌的可调控机制值得进一步深入探究。 相似文献
10.
AIMS: To isolate, identify and assess valienamine production by a soil bacterial isolate from a wheat field in Hangzhou, China. METHODS AND RESULTS: A validamycin A-degrading bacterial strain, numbered ZJB-041, was isolated and identified as Stenotrophomonas maltophilia, based on morphology, physiological tests, ATB system (ID32 GN), and 16S rDNA analysis. The strain was capable of producing valienamine by decomposing validamycin A. After fermentation in shaking flasks at 30 degrees C for 7 days, 96.0% of 34.49 mmol l(-1) of validamycin A was degraded and 2.65 mmol l(-1) of valienamine was obtained. The resting cells of this strain also produced valienamine by degrading validamycin A. After 72 h of incubation in 0.2 mol l(-1) of phosphate buffer (pH 7.5), 90.2% of 17.16 mmol l(-1) of validamycin A was degraded, and 1.77 mmol l(-1) of valienamine was obtained. CONCLUSIONS: Our data suggested that S. maltophilia ZJB-041, a bacterial isolate, has the potential for validamycin A degradation and valienamine production. SIGNIFICANCE AND IMPACT OF THE STUDY: The validamycin A-degrading bacterium could potentially be utilized in the disposal of validamycin residues and in the production of valienamine. 相似文献